🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease

RecruitingNAAges 20 Years - 90 YearsAllKaohsiung Medical University Chung-Ho Memorial Ho…
NCT06548256 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male or female over 20 years old, diagnosed with Parkinson's disease. Exclusion Criteria: * People with Parkinson's disease Dementia, or Lactose Intolerance
💊

What it tests

  • Miyarisan-BM (Clostridium Butyricum Miyairi)
📍

Where

1 site
Kaohsiung Medical Univeristy Hospital
Kaohsiung City, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy